Please check your internet connection and try again.
## HepaMerz (l-Ornithine l-Aspartate)
### Overview
HepaMerz is a combination of two amino acids, l-ornithine and l-aspartate. It is thought to reduce ammonia levels in the blood by promoting its detoxification in the liver and reducing its production in the gut.
### Primary Indications
Treatment of latent and manifest hepatic encephalopathy (HE) in patients with liver disease.
### Adult Dosing
* **Hepatic Encephalopathy (Latent and Manifest):** 3 grams (equivalent to 1 sachet or 10 mL of oral solution) administered orally three times daily.
* **Maximum Daily Dose:** 9 grams.
* **Intravenous Use:** Typically reserved for more severe cases or when oral administration is not possible. Dosing varies widely, but common regimens include 5 grams to 10 grams infused intravenously over 24 hours, or divided doses. **Specific IV dosing should be guided by local protocol and patient response.**
### Pediatric Dosing
There is **limited data** on the use of l-ornithine l-aspartate in pediatric patients. Use is generally not recommended. If used, **dosing should be individualized and carefully monitored by a specialist.**
### Dose Adjustments
No specific dose adjustments are typically required for renal or hepatic impairment, as the drug is metabolized and excreted via hepatic pathways. However, caution is advised in patients with severe liver dysfunction.
### Contraindications
* Known hypersensitivity to l-ornithine, l-aspartate, or any component of the formulation.
* Severe renal failure (serum creatinine > 3 mg/dL).
### Adverse Effects
* **Common:** Nausea, vomiting, abdominal discomfort, flatulence, diarrhea.
* **Less Common:** Headache, dizziness, fatigue, skin reactions.
* **Rare:** Changes in heart rhythm (with very high IV doses).
### Key Drug Interactions
No significant drug interactions have been definitively established.
### Monitoring
* **Clinical:** Monitor for improvement in symptoms of hepatic encephalopathy (e.g., cognitive function, confusion, asterixis).
* **Laboratory:** Periodic monitoring of ammonia levels may be considered, though clinical response is the primary guide. Electrolytes and renal function should be monitored periodically, especially in patients with underlying comorbidities.
### Clinical Pearls
* HepaMerz is most effective when used as an adjunct to standard therapy for liver disease and hepatic encephalopathy.
* Oral administration is generally preferred.
* The oral solution contains fructose; caution is advised in patients with hereditary fructose intolerance.
***
*Disclaimer: This information is intended for healthcare professionals. Always consult the official prescribing information and relevant clinical guidelines before making any treatment decisions. Dosing may vary based on individual patient factors and local protocols.*
